Literature DB >> 31900569

Single Gland, Ectopic Location: Adenomas are Common Causes of Primary Hyperparathyroidism in Children and Adolescents.

Robert D Rampp1, Edna E Mancilla2,3, N Scott Adzick3,4, Michael A Levine2,3, Rachel R Kelz3,5, Douglas L Fraker3,5, Pallavi Iyer6, Brenessa M Lindeman7, Vicente A Mejia1, Herbert Chen7, Heather Wachtel8,9.   

Abstract

BACKGROUND: Primary hyperparathyroidism (PHPT) in children and adolescents is uncommon. Data-driven guidelines for management in pediatric patients are limited.
METHODS: We performed a retrospective cohort analysis of all patients (1997-2017) with PHPT ≤ 21 years of age who underwent parathyroidectomy at three institutions. Clinical and demographic variables were analyzed. Primary operative outcome was cure (normocalcemia > 6 months after surgery); secondary outcome was operative success (intraoperative parathyroid hormone decrease of ≥ 50%).
RESULTS: We identified 86 patients with a median age of 17 years (IQR: 14, 19); 64% (n = 55) were female. The mean preoperative serum calcium was 11.7 mg/dL, median parathyroid hormone (PTH) was 110 pg/mL, and median urine calcium was 4.1 mg/kg/24 h. Preoperatively, sestamibi scan localized in 41/71 patients (58%); neck ultrasound localized in 19/44 (43%). The most common pathology at surgery was a single ectopic parathyroid adenoma in 71% (n = 61). A high incidence of ectopic adenomas (25%, n = 22) was observed, most commonly intrathymic (n = 13), followed by tracheoesophageal groove (n = 5), carotid sheath (n = 2), and intrathyroidal (n = 2). Of 56 patients with retrievable data > 6 months postoperatively, cure was achieved in 55 of 56 patients (98%). One patient who presented to us with parathyromatosis require subsequent reoperation.
CONCLUSION: In this multi-institutional series of PHPT in children and adolescents, the majority were sporadic PHPT and were due to a single adenoma. We observed a high incidence of ectopic parathyroid adenomas, most commonly intrathymic. Given the high risk for ectopic adenoma in pediatric patients, parathyroid surgery in children and adolescents should be performed by experienced surgeons.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31900569      PMCID: PMC7124981          DOI: 10.1007/s00268-019-05362-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  34 in total

Review 1.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

2.  Primary hyperparathyroidism in a paediatric hospital.

Authors:  M L Lawson; S F Miller; G Ellis; R M Filler; S W Kooh
Journal:  QJM       Date:  1996-12

Review 3.  A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults.

Authors:  Jeffrey Roizen; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

4.  Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism.

Authors:  Lee F Starker; Tobias Akerström; William D Long; Alberto Delgado-Verdugo; Patricia Donovan; Robert Udelsman; Richard P Lifton; Tobias Carling
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

Review 5.  Radiation exposure in X-ray-based imaging techniques used in osteoporosis.

Authors:  John Damilakis; Judith E Adams; Giuseppe Guglielmi; Thomas M Link
Journal:  Eur Radiol       Date:  2010-06-18       Impact factor: 5.315

Review 6.  Parathyroid conditions in childhood.

Authors:  Jocelyn F Burke; Herbert Chen; Ankush Gosain
Journal:  Semin Pediatr Surg       Date:  2014-03-15       Impact factor: 2.754

7.  Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.

Authors:  Stephen J Marx
Journal:  J Bone Miner Res       Date:  2017-12-11       Impact factor: 6.741

8.  Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004).

Authors:  Eric Mallet
Journal:  Horm Res       Date:  2008-01-08

9.  Sporadic primary hyperparathyroidism in young individuals: different disease and treatment?

Authors:  Mark S Sneider; Carmen C Solorzano; Raquel E Montano; Charles Anello; George L Irvin; John I Lew
Journal:  J Surg Res       Date:  2008-09-04       Impact factor: 2.192

Review 10.  Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Bruno Carnaille; F Fausto Palazzo; Menno Vriens
Journal:  Langenbecks Arch Surg       Date:  2015-10-08       Impact factor: 3.445

View more
  4 in total

1.  Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).

Authors:  T Weber; C Dotzenrath; H Dralle; B Niederle; P Riss; K Holzer; J Kußmann; A Trupka; T Negele; R Kaderli; E Karakas; F Weber; N Rayes; A Zielke; M Hermann; C Wicke; R Ladurner; C Vorländer; J Waldmann; O Heizmann; S Wächter; S Schopf; W Timmermann; D K Bartsch; R Schmidmaier; M Luster; K W Schmid; M Ketteler; C Dierks; P Schabram; T Steinmüller; K Lorenz
Journal:  Langenbecks Arch Surg       Date:  2021-04-21       Impact factor: 3.445

2.  Ectopic Parathyroid Adenoma in an 11-Year-Old Girl: Case Report and Literature Review.

Authors:  Myrto Eleni Flokas; Gulnigor Ganieva; Amanda Grieco; Levon Agdere
Journal:  AACE Clin Case Rep       Date:  2020-11-28

3.  "Primary Hyperparathyroidism (PHPT) in Children: Two Case Reports and Review of the Literature".

Authors:  Gerdi Tuli; Jessica Munarin; Daniele Tessaris; Raffaele Buganza; Patrizia Matarazzo; Luisa De Sanctis
Journal:  Case Rep Endocrinol       Date:  2021-04-13

4.  Primary Hyperparathyroidism From Ectopic Parathyroid Adenoma in a 12-Year-Old With Slipped Capital Femoral Epiphysis.

Authors:  Rebecca J Vitale; Hester F Shieh; Biren P Modi; Rebecca J Gordon
Journal:  J Endocr Soc       Date:  2022-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.